https://adisinsight.springer.com/drugsafety/803153428?error=cookies_not_supported&code=9664d1b1-29d3-49e2-b587-f152b5310786
Temozolomide/leflunomide/meropenem - AdisInsight
Two patients [ages and sexes not stated] and a woman [age not stated] developed severe exanthematous eruption, maculopapular eruption, and DRESS following
temozolomideleflunomidemeropenemadisinsight
https://www.cochrane.org/evidence/CD002047_leflunomide-treatment-rheumatoid-arthritis
Leflunomide for the treatment of rheumatoid arthritis | Cochrane
for therheumatoid arthritisleflunomidetreatmentcochrane
https://adisinsight.springer.com/drugsafety/801056978?error=cookies_not_supported&code=0f5c91ae-e5c9-4d40-9781-27e6aaef658e
Leflunomide-linked ILD reported to ADRAC - AdisInsight
To date, Australian ADRAC has received 669 reports associated with leflunomide use and, of those, 142 reports involved respiratory symptoms. Furthermore, there
leflunomidelinkedildreportedadisinsight
https://pubmed.ncbi.nlm.nih.gov/9200452/
In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in...
Two activities have been identified for the immunosuppressive metabolite of leflunomide, A77 1726: inhibition of dihydroorotate dehydrogenase (DHO-DHase), an...
in vivomechanism
https://www.bennett.ox.ac.uk/papers/10.1111/bcp.16062/
The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors...
This study investigated whether disease-modifying anti-rheumatic drug (DMARD) safety monitoring was affected during the COVID-19 pandemic, with additional...
the impact
https://adisinsight.springer.com/drugsafety/803928978?error=cookies_not_supported&code=390eb86a-066d-47f7-a6f4-b02f6091e7bc
Leflunomide - AdisInsight
A 61-year-old woman with long-standing seropositive rheumatoid arthritis experienced cavitary pulmonary nodules, necrotising granulomatous inflammation and
leflunomideadisinsight
https://adisinsight.springer.com/drugsafety/803512443?error=cookies_not_supported&code=bdc5fce6-a539-4431-a6a0-5d72ae4426e4
Hydroxychloroquine/leflunomide/prednisone - AdisInsight
An adult woman [exact age at onset not stated] developed unspecified infections following immunosuppressive treatment with prednisone, hydroxychloroquine, and
hydroxychloroquineleflunomideprednisoneadisinsight
https://adisinsight.springer.com/drugsafety/803775893?error=cookies_not_supported&code=f99692e1-8c1e-4b77-a570-c0ff1a4947f5
Leflunomide - AdisInsight
A 32-year-old woman developed DRESS syndrome during treatment with leflunomide for arthritis.The woman presented with complaints of rash, fever for 17 days,
leflunomideadisinsight